PUBLISHER: TechNavio | PRODUCT CODE: 1544532
PUBLISHER: TechNavio | PRODUCT CODE: 1544532
The transcatheter aortic valve replacement market is forecasted to grow by USD 2401.1 mn during 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the transcatheter aortic valve replacement market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing aging population globally, growing demand for minimally invasive procedures, and growing awareness of valvular heart diseases.
Technavio's transcatheter aortic valve replacement market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 6.23% |
CAGR | 6.78% |
Incremental Value | $2401.1 mn |
By End-user
By Type
By Geographical Landscape
This study identifies the growing expansion of indications for tavr procedures as one of the prime reasons driving the transcatheter aortic valve replacement market growth during the next few years. Also, growing miniaturization and development of next-generation tavr devices and integration of artificial intelligence (ai) and robotics into tavr procedures will lead to sizable demand in the market.
The report on the transcatheter aortic valve replacement market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading transcatheter aortic valve replacement market vendors that include 4C Medical Technologies Inc., Abbott Laboratories, Anteris Technologies Ltd., Artivion Inc., Biosensors International Group Ltd., Boston Scientific Corp., Colibri Heart Valve LLC, Edwards Lifesciences Corp., Genesis Medtech International Pvt. Ltd., HighLife SAS, JenaValve Technology Inc., LifeNet Health Inc., LivaNova PLC, Medinol Ltd., Medtronic Plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corp., Shockwave Medical Inc., Siemens AG, and Venus Medtech Hangzhou Inc.. Also, the transcatheter aortic valve replacement market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: